KR20150063559A - 층상 이중 수산화물 - Google Patents

층상 이중 수산화물 Download PDF

Info

Publication number
KR20150063559A
KR20150063559A KR1020157011694A KR20157011694A KR20150063559A KR 20150063559 A KR20150063559 A KR 20150063559A KR 1020157011694 A KR1020157011694 A KR 1020157011694A KR 20157011694 A KR20157011694 A KR 20157011694A KR 20150063559 A KR20150063559 A KR 20150063559A
Authority
KR
South Korea
Prior art keywords
ldh
active
active anion
compound
anion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020157011694A
Other languages
English (en)
Korean (ko)
Inventor
클래어 톰슨
코데로 마르셀로 레오나르도 브라보
더모트 마이클 오'해어
Original Assignee
옥스포드 파마사이언스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 옥스포드 파마사이언스 리미티드 filed Critical 옥스포드 파마사이언스 리미티드
Publication of KR20150063559A publication Critical patent/KR20150063559A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
KR1020157011694A 2012-10-05 2013-10-01 층상 이중 수산화물 Ceased KR20150063559A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1217911.5 2012-10-05
GBGB1217911.5A GB201217911D0 (en) 2012-10-05 2012-10-05 Layered double hydroxides
PCT/GB2013/052554 WO2014053822A1 (en) 2012-10-05 2013-10-01 Layered double hydroxides

Publications (1)

Publication Number Publication Date
KR20150063559A true KR20150063559A (ko) 2015-06-09

Family

ID=47294361

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157011694A Ceased KR20150063559A (ko) 2012-10-05 2013-10-01 층상 이중 수산화물

Country Status (16)

Country Link
US (1) US9642919B2 (cg-RX-API-DMAC7.html)
EP (2) EP2929876B1 (cg-RX-API-DMAC7.html)
JP (1) JP6363082B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150063559A (cg-RX-API-DMAC7.html)
CN (1) CN104853748A (cg-RX-API-DMAC7.html)
AU (2) AU2013326298B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015007529A2 (cg-RX-API-DMAC7.html)
CA (1) CA2887059A1 (cg-RX-API-DMAC7.html)
EA (1) EA034124B1 (cg-RX-API-DMAC7.html)
GB (1) GB201217911D0 (cg-RX-API-DMAC7.html)
IL (1) IL237947B (cg-RX-API-DMAC7.html)
IN (1) IN2015DN02576A (cg-RX-API-DMAC7.html)
MX (1) MX2015004188A (cg-RX-API-DMAC7.html)
PH (1) PH12015500744B1 (cg-RX-API-DMAC7.html)
WO (1) WO2014053822A1 (cg-RX-API-DMAC7.html)
ZA (2) ZA201502510B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201520762D0 (en) * 2015-11-24 2016-01-06 Isis Innovation Novel pharmaceutical compositions
JP6557597B2 (ja) * 2015-12-25 2019-08-07 共栄社化学株式会社 層状複水酸化物
US10882753B2 (en) 2016-09-15 2021-01-05 Paris Sciences Et Lettres—Quartier Latin Method for exchanging interlayer anions of a layered double hydroxide
CN109432450B (zh) * 2018-11-23 2021-07-13 北京化工大学 一种超分子纳米化学动力药物及其在肿瘤治疗方面的应用
EP3957604B1 (en) * 2019-04-19 2025-07-09 National Institute for Materials Science Nitrogen-based gas sustained release agent, nitrogen-based gas sustained release body comprising same, nitrogen-based gas sustained release method using sustained release body, breathing instrument, wrapping body, and sustained release device
CA3194835A1 (en) 2020-10-17 2022-04-21 David Anderson Formulation and noncovalent stabilization of olivetolic acid derivatives
WO2025192959A1 (ko) * 2024-03-13 2025-09-18 연세대학교 산학협력단 층상형 금속 인화물 혼성체 촉매, 이의 제조방법 및 이를 구비하는 수전해 장치

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606619A (ja) 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd 鉄分欠乏症処置剤及びその製法
US5079203A (en) 1990-05-25 1992-01-07 Board Of Trustees Operating Michigan State University Polyoxometalate intercalated layered double hydroxides
JP3681480B2 (ja) * 1996-09-27 2005-08-10 エーザイ株式会社 薬物の不快な味を隠蔽する組成物
GB0030460D0 (en) * 2000-12-14 2001-01-24 Isis Innovation Drug delivery system
US6924409B2 (en) 2000-12-19 2005-08-02 Babcock & Wilcox Volund Aps Method for reducing the leaching of oxyanion forming elements, in particular chromium, from hazardous waste
JP2004091421A (ja) * 2002-09-03 2004-03-25 Tayca Corp アスコルビン酸を取り込んだ層状複水酸化物およびそれを含む化粧料組成物
US20040138511A1 (en) 2003-01-10 2004-07-15 James Butler Aromatic alkylation process with direct recycle
AU2003902178A0 (en) 2003-05-07 2003-05-22 Commonwealth Scientific And Industrial Research Organisation Stabilization of waste material
CN1297276C (zh) 2004-06-14 2007-01-31 北京化工大学 5－氨基水杨酸插层药物缓释剂及其制备方法
US20090108233A1 (en) * 2004-12-24 2009-04-30 The Univeristy Of Queensland Preparation of suspensions
US20060140994A1 (en) 2004-12-27 2006-06-29 Bagwell Alison S Application of an antimicrobial agent on an elastomeric article
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
CN100462071C (zh) * 2006-09-22 2009-02-18 北京化工大学 一种磁性超分子插层结构缓释型布洛芬及其制备方法
CN101493404B (zh) 2008-01-21 2011-08-10 安徽帝元生物科技有限公司 一种化肥养分控失剂控失率的检测方法
CN101440281B (zh) * 2008-11-25 2011-11-23 北京化工大学 苯并咔唑插层水滑石复合发光材料及其制备方法
ZA201000350B (en) 2009-02-05 2010-12-29 Univ Pretoria A degradable polymeric material
CN101507819B (zh) * 2009-03-27 2011-01-05 北京化工大学 一种大粒径药物插层水滑石及其制备方法
CN101597474B (zh) 2009-07-03 2012-10-17 北京化工大学 增甘磷插层结构选择性红外吸收材料及其制备方法与应用
US20110040006A1 (en) 2009-08-17 2011-02-17 Basf Se Compositions with Improved Dirt Pickup Resistance Comprising Layered Double Hydroxide Particles
CN102218043B (zh) 2011-06-14 2013-03-27 宁夏医科大学 Ldh超分子组装型阿司匹林缓释片及其制备方法

Also Published As

Publication number Publication date
ZA201702869B (en) 2018-08-29
AU2013326298A1 (en) 2015-04-23
WO2014053822A1 (en) 2014-04-10
US9642919B2 (en) 2017-05-09
IL237947B (en) 2018-04-30
AU2017219016B2 (en) 2018-07-26
EP2903598A1 (en) 2015-08-12
PH12015500744A1 (en) 2015-05-25
CN104853748A (zh) 2015-08-19
EA034124B1 (ru) 2019-12-30
CA2887059A1 (en) 2014-04-10
EP2929876B1 (en) 2019-12-25
ZA201502510B (en) 2017-09-27
BR112015007529A2 (pt) 2017-07-04
EA201590673A1 (ru) 2015-08-31
AU2013326298B2 (en) 2017-10-05
JP6363082B2 (ja) 2018-07-25
JP2016500667A (ja) 2016-01-14
GB201217911D0 (en) 2012-11-21
IN2015DN02576A (cg-RX-API-DMAC7.html) 2015-09-11
MX2015004188A (es) 2015-07-17
PH12015500744B1 (en) 2015-05-25
US20150258212A1 (en) 2015-09-17
AU2017219016A1 (en) 2017-09-07
EP2903598B1 (en) 2019-05-01
EP2929876A1 (en) 2015-10-14
WO2014053822A4 (en) 2014-05-30

Similar Documents

Publication Publication Date Title
AU2017219016B2 (en) Layered double hydroxides
EP1993514B1 (en) Granular material comprising water-insoluble inorganic phosphate binders
RU2570007C2 (ru) Гидроксид карбонат лантана, оксикарбонат лантана и способы их получения и применения
EP2194972B1 (en) Mixed metal compounds used as antacids
KR101951857B1 (ko) 마그헤마이트 또는 마그헤마이트/마그네타이트에 기초한 나노미립자 인산염 흡착제, 이의 제법 및 용도
EP3611131A1 (en) Magnesium-iron layered double hydroxides, their manufacture and their use for treatment of hyperphosphataemia
CN105764492B (zh) 包含磷酸盐结合剂颗粒的药物组合物
JP2007538098A (ja) 機能性−活性有機化合物がインターカレートされた組成物
JP2016500667A5 (cg-RX-API-DMAC7.html)
US10272057B2 (en) Layered double hydroxides
CN101378730B (zh) 含有水不溶性无机磷酸盐结合剂的粒状物质
Fisher Pharmaceutical applications of layered double hydroxides
AU2013263790A1 (en) Granular Material Comprising Water-Insoluble Inorganic Phosphate Binders
AU2016213745A1 (en) Granular Material Comprising Water-Insoluble Inorganic Phosphate Binders
HK1142524A (en) Mixed metal compounds used as antacids

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20150504

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180904

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200108

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20200710

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20200108

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I